Condition

Splenectomy

ClinicalTrials.gov condition label

Clinical trials6

Recruiting2

Common interventions6

Lead sponsors shown2

Clinical trials

6 shown

Efficacy of Apixaban in Treating Portal Vein Thrombosis Occurring More Than One Year After LSDNCT07461532 · 2026-04-01

Efficacy of Apixaban in the Treatment of Portal Vein Thrombosis Occurring More Than One Year After LSNCT07461545 · 2026-04-01

Vagus Nerve-guided Robotic-assisted Splenectomy and Azygoportal DisconnectionNCT05300516 · 2022-04-01

Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal DisconnectionNCT05304455 · 2022-04-01

Laparoscopic Splenectomy and Azygoportal Disconnection With Intraoperative Endoscopic Variceal LigationNCT04244487 · 2020-01-03

Modified Vagus Nerve-preserving Laparoscopic Splenectomy and Azygoportal DisconnectionNCT03396796 · 2018-04-09

Common interventions

Apixaban 2.5 MGDRUG3 Dipyridamole 25Mg TabDRUG1 laparoscopic splenectomy and azygoportal disconnection with intraoperative endoscopic variceal ligationPROCEDURE1 subcutaneous Low Molecular Weight HeparinDRUG1 vagus nerve-guided groupPROCEDURE1 Vagus nerve-preserving groupPROCEDURE1

Leading sponsors

Northern Jiangsu People's Hospital5 Yangzhou University1

Trial status mix

COMPLETED4

RECRUITING2

Phase mix

NA6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.